These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 2323092)

  • 1. A linkage study of malignant hyperthermia (MH).
    Bender K; Senff H; Wienker TF; Spiess-Kiefer C; Lehmann-Horn F
    Clin Genet; 1990 Mar; 37(3):221-5. PubMed ID: 2323092
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-13.2.
    McCarthy TV; Healy JM; Heffron JJ; Lehane M; Deufel T; Lehmann-Horn F; Farrall M; Johnson K
    Nature; 1990 Feb; 343(6258):562-4. PubMed ID: 2300206
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic heterogeneity and HOMOG analysis in British malignant hyperthermia families.
    Robinson R; Curran JL; Hall WJ; Halsall PJ; Hopkins PM; Markham AF; Stewart AD; West SP; Ellis FR
    J Med Genet; 1998 Mar; 35(3):196-201. PubMed ID: 9541102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel ryanodine receptor mutation and genotype-phenotype correlation in a large malignant hyperthermia New Zealand Maori pedigree.
    Brown RL; Pollock AN; Couchman KG; Hodges M; Hutchinson DO; Waaka R; Lynch P; McCarthy TV; Stowell KM
    Hum Mol Genet; 2000 Jun; 9(10):1515-24. PubMed ID: 10888602
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [What significance to genotype changes have in diagnosis of malignant hyperthermia?].
    Steinfath M; Scholz J; Singh S; Wappler F
    Anasthesiol Intensivmed Notfallmed Schmerzther; 1996 Aug; 31(6):334-43. PubMed ID: 8962927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of the malignant hyperthermia susceptibility locus to human chromosome 19q12-q13.2.
    Healy JM; Lehane M; Heffron JJ; Farrell M; Johnson K; McCarthy TV
    Biochem Soc Trans; 1990 Apr; 18(2):326. PubMed ID: 2379741
    [No Abstract]   [Full Text] [Related]  

  • 7. Diagnosis of susceptibility to malignant hyperthermia with flanking DNA markers.
    Healy SJ; Heffron JJ; Lehane M; Bradley DG; Johnson K; McCarthy TV
    BMJ; 1991 Nov; 303(6812):1225-8. PubMed ID: 1684123
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic linkage analysis of chromosome 19 markers in malignant hyperthermia.
    Ball SP; Dorkins HR; Ellis FR; Hall JL; Halsall PJ; Hopkins PM; Mueller RF; Stewart AD
    Br J Anaesth; 1993 Jan; 70(1):70-5. PubMed ID: 8431338
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linkage of malignant hyperthermia and hyperkalemic periodic paralysis to the adult skeletal muscle sodium channel (SCN4A) gene in a large pedigree.
    Moslehi R; Langlois S; Yam I; Friedman JM
    Am J Med Genet; 1998 Feb; 76(1):21-7. PubMed ID: 9508059
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ryanodine receptor gene is a candidate for predisposition to malignant hyperthermia.
    MacLennan DH; Duff C; Zorzato F; Fujii J; Phillips M; Korneluk RG; Frodis W; Britt BA; Worton RG
    Nature; 1990 Feb; 343(6258):559-61. PubMed ID: 1967823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence for genetic heterogeneity in malignant hyperthermia susceptibility.
    Levitt RC; Nouri N; Jedlicka AE; McKusick VA; Marks AR; Shutack JG; Fletcher JE; Rosenberg H; Meyers DA
    Genomics; 1991 Nov; 11(3):543-7. PubMed ID: 1774061
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent developments in the molecular genetics of malignant hyperthermia: implications for future diagnosis at the DNA level.
    McCarthy TV; Healy JM; Lehane M; Heffron JJ
    Acta Anaesthesiol Belg; 1990; 41(2):107-12. PubMed ID: 1973552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multipoint mapping of the central core disease locus.
    Schwemmle S; Wolff K; Palmucci LM; Grimm T; Lehmann-Horn F; Hübner C; Hauser E; Iles DE; MacLennan DH; Müller CR
    Genomics; 1993 Jul; 17(1):205-7. PubMed ID: 8406450
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence for linkage of the central core disease locus to the proximal long arm of human chromosome 19.
    Kausch K; Lehmann-Horn F; Janka M; Wieringa B; Grimm T; Müller CR
    Genomics; 1991 Jul; 10(3):765-9. PubMed ID: 1889818
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombination between the postulated CCD/MHE/MHS locus and RYR1 gene markers.
    Fagerlund TH; Islander G; Ranklev-Twetman E; Berg K
    Clin Genet; 1996 Dec; 50(6):455-8. PubMed ID: 9147872
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The substitution of Arg for Gly2433 in the human skeletal muscle ryanodine receptor is associated with malignant hyperthermia.
    Phillips MS; Khanna VK; De Leon S; Frodis W; Britt BA; MacLennan DH
    Hum Mol Genet; 1994 Dec; 3(12):2181-6. PubMed ID: 7881417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Segregation of malignant hyperthermia, central core disease and chromosome 19 markers.
    Curran JL; Hall WJ; Halsall PJ; Hopkins PM; Iles DE; Markham AF; McCall SH; Robinson RL; West SP; Bridges LR; Ellis FR
    Br J Anaesth; 1999 Aug; 83(2):217-22. PubMed ID: 10618932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Linkage studies of Myotonia congenita and Paramyotonia congenita.
    Bender K; Senff H; Steiert A; Lagodny H; Wienker TF; Koch M
    Clin Genet; 1989 Aug; 36(2):92-9. PubMed ID: 2766573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant hyperthermia--a large kindred linked to the RYR1 gene.
    Wallace AJ; Wooldridge W; Kingston HM; Harrison MJ; Ellis FR; Ford PM
    Anaesthesia; 1996 Jan; 51(1):16-23. PubMed ID: 8669559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic recombination between malignant hyperthermia and calcium release channel in skeletal muscle.
    Fagerlund T; Islander G; Ranklev E; Harbitz I; Hauge JG; Møkleby E; Berg K
    Clin Genet; 1992 May; 41(5):270-2. PubMed ID: 1318804
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.